-
Dr Sanil RegeFebruary 19, 2020
Time to read: 4 minutes
Depression occurs commonly in schizophrenia and first-episode psychosis (FEP) and challenges the Kraepelinian Dichotomy betwe...
READ MOREDr Sanil RegeFebruary 17, 2020Time to read: 8 minutes
The National Institute of Mental Health-sponsored Sequenced Treatment Alternatives to Relieve Depression (STAR*D) showed that approximately 30% of MDD p...
READ MOREDr Sanil Rege, Dr James GrahamFebruary 13, 2020Time to read: 8 minutes
Physical activity is recommended in clinical practice as a viable intervention for the treatment of subthreshold, mild, and moderate depression. Researc...
READ MOREDr Sanil RegeFebruary 5, 2020Time to read: 14–16 minutes
Depression affects up to 350 million people around the world, but response rates to a first-line antidepressant can be as low as 50%. ...
READ MOREOctober 2, 2019Dr Sanil Rege talks with Prof Martin Katzman, an expert in the field of mood and anxiety disorders. Professor Martin Katzman is the Clinic Direct...
READ MORESeptember 9, 2019Time to read: 2 minutes
This article is based on the talk by Prof Allan Young at RCPsychIC 2019. He is Chair of Mood Disorders, Director of the Centre for Affective Disorders i...
READ MOREDr Sanil Rege, Dr James GrahamAugust 29, 2019Time to read: 9 minutes
Throughout the history of medicine, thousands of drugs have been developed, but only one has been influential enough to earn the title o...
READ MOREDr Sanil Rege, Dr James GrahamAugust 26, 2019Time to read: 4 minutes
Lamotrigine is a synthetic phenyltriazine drug with analgesic and antiepileptic properties. It is primarily used as an anticonvulsant for the adjunctive...
READ MORE
Recent Comments